Efficacy and Tolerability of Moxifloxacin in 2338 Patients with Acute Exacerbation of Chronic Bronchitis

被引：0
|
作者：
J. Barth
H. Landen
机构：
[1] Berufsgenossenschaftliche Kliniken Bergmannstrost,
[2] Germany Bayer Vital GmbH,undefined
[3] BG-PH/PMS-Management D162,undefined
来源：
Clinical Drug Investigation | 2003年 / 23卷
关键词：
Moxifloxacin; Chronic Bronchitis; Clinical Success Rate; Moraxella Catarrhalis; General Practice Setting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 10
页数：9
相关论文
共 50 条
  • [1] Efficacy and tolerability of moxifloxacin in 2338 patients with acute exacerbation of chronic bronchitis
    Barth, J
    Landen, H
    CLINICAL DRUG INVESTIGATION, 2003, 23 (01) : 1 - 10
  • [2] Efficacy of antimicrobials for acute exacerbation of chronic bronchitis episodes
    Chang, Julie A.
    Malesker, Mark A.
    Schuller, Daniel
    Morrow, Lee
    Wichman, Tammy
    Dewan, Naresh A.
    Destache, Christopher J.
    CHEST, 2007, 132 (04) : 530S - 530S
  • [3] Clinical efficacy of telithromycin in the acute exacerbation of chronic bronchitis
    Pachón, J
    Cordero, E
    Rodríguez, MJ
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 : 28 - 32
  • [4] EFFICACY AND TOLERABILITY OF AZITHROMYCIN VERSUS AMOXICILLIN/CLAVULANIC ACID IN ACUTE PURULENT EXACERBATION OF CHRONIC-BRONCHITIS
    BEGHI, G
    BERNI, F
    CARRATU, L
    CASALINI, A
    CONSIGLI, G
    DANTO, M
    GIOIA, V
    MOLINO, A
    PAIZIS, G
    VAGHI, A
    JOURNAL OF CHEMOTHERAPY, 1995, 7 (02) : 146 - 152
  • [5] The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis
    DeAbate, CA
    Mathew, CP
    Warner, JH
    Heyd, A
    Church, D
    RESPIRATORY MEDICINE, 2000, 94 (11) : 1029 - 1037
  • [6] Pharmacokinetic and Pharmacodynamic Aspects of Oral Moxifloxacin 400 mg/day in Elderly Patients with Acute Exacerbation of Chronic Bronchitis
    Federico Pea
    Federica Pavan
    Emilio Lugatti
    Flavio Dolcet
    Giovanni Talmassons
    Maria Consuelo Screm
    Mario Furlanut
    Clinical Pharmacokinetics, 2006, 45 : 287 - 295
  • [7] Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis
    Pea, F
    Pavan, F
    Lugatti, E
    Dolcet, F
    Talmassons, G
    Screm, MC
    Furlanut, M
    CLINICAL PHARMACOKINETICS, 2006, 45 (03) : 287 - 295
  • [8] Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis
    Cazzola, M
    Matera, MG
    Donnarumma, G
    Tufano, MA
    Sanduzzi, A
    Marchetti, F
    Blasi, F
    CHEST, 2005, 128 (04) : 2093 - 2098
  • [9] Acute exacerbation of chronic bronchitis: patients, antibiotherapy, and guidelines
    Gaillat, J
    Duprat-Lomon, I
    Mortier, N
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 (11): : 538 - 545
  • [10] Rapid resolution of symptoms with moxifloxacin therapy in 7223 patients with acute exacerbation of chronic bronchitis - Comparison with prior macrolide treatment
    Bauer, T
    Landen, H
    CLINICAL DRUG INVESTIGATION, 2002, 22 (10) : 641 - 651
12345